Bionik Laboratories Corp. (BNKL)

[venturecapp]

Bionik presented at 14th Annual BIO Investor Forum

Bionik Laboratories Corp. a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders gave a presentation at the held October 20-21, 2015 at the Parc 55 in San Francisco, California.

Peter Bloch, CEO of Bionik, presented a corporate overview. As part of his presentation he reviewed the Company's plans for the clinical development and commercial deployment of its primary product ARKE, a proprietary lower-body exoskeleton robotic device that is designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Mr. Bloch also discussed Bionik's near-term strategy to expand and develop a robust product portfolio both internally and by acquiring or licensing synergistic products and technologies.

A live webcast of the presentation is available on Bionik's IR Calendar in the Investor Relations section of the Company's website. A webcast replay is available and will be archived for 30 days.